Spring Impact Capital closes $14-million fund to grow Canada’s climate and healthtech ecosystem
The Vancouver impact fund has already invested $2 million across eight Canadian startups.
The Vancouver impact fund has already invested $2 million across eight Canadian startups.
Series D funding will support commercialization of Halifax company’s Eye90 microspheres.
Vancouver-based studio’s inaugural fund is fetching $10 million to help build pet health startups.
Calgary-based Corbett joins a month after Isaac Souweine left the fund.
Entrepreneurs say slow policy and weak procurement limit Canadians’ access to aging and fertility tech.
Startup will expand in Canada and the UK while laying groundwork in the US, Europe, and Middle East.
Canadian telehealth company expands beyond on-demand prescriptions for stigmatized conditions.
Montréal startup aims to bring liquid biopsy tests to Quebec patients outside major centres.
Kitchener-Waterloo healthtech startup eyes Series B to fuel US commercialization.
Vancouver firm’s AI platform will generate chemical compounds based on Merck’s therapeutic targets.
Study shows Tatum’s treatment “uncloaked” cancer cells and wiped out tumours in mice.
“Mutual” decision leaves Souweine searching for new opportunities in Canadian tech.
Weston-backed VC adds Ali to help lead its cleantech and healthtech innovation fund.
Surgeries were the first the company has tried outside of the US.
Industry leaders say program could be “turning point” for Ontario’s health system.